舒利迭对重度稳定期COPD患者辅助治疗的观察  

Observe on Seretide in adjuvant therapy of patients with stable severe chronic obstructive pulmonary

作　　者：邬明玉[1] 罗晓寒[1] 

机构地区：[1]罗江县人民医院内科,四川618500

出　　处：《齐齐哈尔医学院学报》2013年第3期332-333,共2页Journal of Qiqihar Medical University

摘　　要：目的探讨舒利迭对重度稳定期慢性阻塞性肺疾病(COPD)辅助治疗的疗效。方法按入院先后顺序,70例稳定期中重度COPD患者被随机分为对照组和观察组(n=35)。在止咳、平喘、抗感染等常规治疗基础上,对照组给予口服舒弗美(缓释茶碱)片0.2 g,2次/d,而观察组给予舒利迭吸入,每次l喷,2次/d;疗程均为8周。对各项临床指标进行观察比较。结果治疗后,观察组的肺功能、血气指标及临床症状评分改善情况均明显优于对照组,组间差异具有统计学意义(P<0.05)。结论舒利迭辅助治疗稳定期重度COPD优于舒服美,能显著改善患者的肺功能及临床症状。Objective To explore the clinical efficacy of Seretide in adjuvant treatment of patients with severe chronic obstructive pulmonary disease （COPD）. Methods According to admission ,70 patients with stable severe COPD were randomly divided into control and observation group （ n = 35 ）. On the basis of the conventional treatment of cough, asthma, anti -infection, the control group was given oral Shouf beauty （theophylline） tablets 0.2 g, 2 times/d, while the experimental group were given Seretide inhalation, every time lspray, 2 times/d; treatment lasted for 8 weeks. Before and after treatment of lung function, blood gas analysis and clinical symptom score improvement was observed. Results After treatment observation group lung function, blood gas analysis and improvement of clinical symptom scores were significantly better than the control, the differences was significant between the groups （ P 〈 0. 05 ）. Conclusions Seretide better than the Shouf beauty in adjuvant treatment of patients with stable severe COPD, can significantly improve lung function and clinical symptoms..

关 键 词：舒利迭 舒弗美 重度 稳定期 慢性阻塞性肺疾病 疗效 

分 类 号：R563[医药卫生—呼吸系统]